publication venue for
- Pricing methods in outcome-based contracting: 6: adherence-based pricing.. 23:1256-1265. 2020
- Pricing methods in outcome-based contracting: 1: cost effectiveness analysis and cost-utility analysis-based pricing.. 23:1215-1222. 2020
- Pricing methods in outcome-based contracting: 2: willingness-to-pay-based pricing.. 23:1223-1229. 2020
- Pricing methods in outcome-based contracting: 3: reference-based pricing.. 23:1230-1236. 2020
- Pricing methods in outcome-based contracting: 4: safety-based pricing.. 23:1237-1245. 2020
- Pricing methods in outcome-based contracting: 5: risk of efficacy failure-based pricing.. 23:1246-1255. 2020
- Pricing methods in outcome-based contracting: integration analysis of the six dimensions (6 s).. 23:1266-1272. 2020
- A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial.. 23:64-69. 2020
- Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US.. 22:187-195. 2019
- Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial.. 15:125-133. 2012
- Economic impact of potential drug-drug interactions in opioid analgesics.. 14:390-396. 2011
- Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial.. 13:428-437. 2010
- Medical and cost burden of atherosclerosis among patients treated in routine clinical practice.. 13:500-507. 2010